Swiss National Bank Morphic Holding, Inc. Transaction History

Swiss National Bank

$143 Billion
Q2 2024

A detailed history of Swiss National Bank transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Swiss National Bank holds 58,900 shares of MORF stock, worth $3.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

58,900

Previous 58,900 -0.0%

Holding current value

$3.36 Million

Previous $2.07 Million 3.23%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$26.64 - $40.31 $58,608 - $88,682	2,200 Added 3.88%	58,900 $2.07 Million
Q4 2023 Feb 06, 2024	SELL	$19.95 - $31.0 $53,865 - $83,700	-2,700 Reduced 4.55%	56,700 $1.64 Million
Q3 2023 Nov 08, 2023	BUY	$21.33 - $59.42 $12,797 - $35,652	600 Added 1.02%	59,400 $1.36 Million
Q2 2023 Aug 09, 2023	BUY	$34.33 - $62.11 $446,290 - $807,430	13,000 Added 28.38%	58,800 $3.37 Million
Q1 2023 May 10, 2023	SELL	$26.01 - $48.69 $137,853 - $258,057	-5,300 Reduced 10.37%	45,800 $1.72 Million
Q4 2022 Feb 08, 2023	BUY	$24.14 - $30.37 $28,968 - $36,444	1,200 Added 2.4%	51,100 $1.37 Million
Q3 2022 Nov 09, 2022	BUY	$22.23 - $33.37 $44,460 - $66,740	2,000 Added 4.18%	49,900 $1.41 Million
Q2 2022 Aug 09, 2022	BUY	$19.74 - $43.01 $82,908 - $180,642	4,200 Added 9.61%	47,900 $1.04 Million
Q1 2022 May 09, 2022	BUY	$36.25 - $52.02 $134,125 - $192,474	3,700 Added 9.25%	43,700 $1.76 Million
Q3 2021 Nov 08, 2021	BUY	$53.61 - $67.5 $21,444 - $27,000	400 Added 1.01%	40,000 $2.27 Million
Q2 2021 Aug 06, 2021	SELL	$45.13 - $64.99 $257,241 - $370,442	-5,700 Reduced 12.58%	39,600 $2.27 Million
Q1 2021 May 07, 2021	BUY	$29.77 - $84.85 $523,952 - $1.49 Million	17,600 Added 63.54%	45,300 $2.87 Million
Q4 2020 Feb 05, 2021	BUY	$25.66 - $34.55 $710,782 - $957,034	27,700 New	27,700 $929,000

Others Institutions Holding MORF

# of Institutions

140

Shares Held

38.7M

Call Options Held

4.2K

Put Options Held

200K

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Morphic Holding, Inc. Transaction History